• Small Bone Innovations

  Participated · Debt Financing · Dec 2009

  Small Bone Innovations (SBi) develops and commercializes implants and technologies for small bones and joints, with its flagship STAR total ankle replacement and an upper and lower limb product portfolio. The company was founded in 2004 by Viscogliosi Brothers and has facilities in New York, NY; Morrisville, PA; Péronnas, France; Donaueschingen, Germany; and Kuala Lumpur, Malaysia, and has sold products in 46 countries. Management reports positive sales and business performance this year, with continued revenue growth and substantial reductions in operating expenses. SBi plans a more aggressive buildup of its direct sales organization in the United States to drive further adoption of the STAR ankle. The company is using new financing to refinance existing indebtedness and provide working capital to accelerate sales across its portfolio. Small Bone Innovations focuses on devices and treatments for small-bone joint repair and trauma reconstruction across the hand, upper limb and lower extremity. Its product portfolio includes the STAR™ total ankle joint replacement system and a stable core upper limb arthroplasty and trauma reconstruction line. The company plans to use proceeds from the latest financing to continue driving growth of the STAR ankle system and support its existing product portfolio. SBi was founded in 2004 and previously raised $144m in Series D and Series C rounds in June 2009. The company operates facilities in New York, NY; Morrisville, PA; Bourg-en-Bresse, France; Donaueschingen, Germany; and Kuala Lumpur, Malaysia. The recent capital infusion is intended to support continued commercial and product growth in its targeted small-bone joint markets. Small Bone Innovations develops orthopedic technologies and treatments focused on small bones and joints, notably its S.T.A.R.® total ankle replacement system. The company plans a worldwide rollout of the S.T.A.R. system, using new capital to fund inventory and expand surgeon education and training. Management says proceeds will also support new and expanded product offerings for both upper and lower limb anatomies and related clinical studies. SBi operates facilities in New York, Morrisville (PA), Bourg-en-Bresse (France), Donaueschingen (Germany) and Kuala Lumpur (Malaysia). The company distributes its products and technologies in more than 50 countries. Anthony G. Viscogliosi is Chairman & CEO. Small Bone Innovations (SBi) develops technologies and treatments for small bones and joints, with products for upper and lower limb anatomies. The company plans to introduce new products and improved versions in 2010 and to develop and initiate several studies to support clinical understanding of its portfolio. SBi closed a $30M credit facility to accelerate business expansion and refinance existing indebtedness. The facility allowed the company to fully repay approximately $13M of its existing debt. In conjunction with the credit facility closing, Helmut D. Link and the investor group of Link America, Inc. made an equity investment in SBi. The company was founded in 2004 and operates facilities in New York, NY; Morrisville, PA; Bourg-en-Bresse, France; Donaueschingen, Germany; and Kuala Lumpur, Malaysia.

No current team members are available.